DNAH17 Activators represent a specific class of chemical compounds designed or identified for their potential to modulate the activity of DNAH17, which stands for Dynein Axonemal Heavy Chain 17. DNAH17 is a member of the dynein family of motor proteins, primarily known for its crucial role in ciliary and flagellar movement. These complex cellular structures, cilia, and flagella, play essential roles in processes like cellular motility, fluid transport, and signal transduction. Dyneins, including DNAH17, are responsible for the movement of microtubules within cilia and flagella, enabling these structures to function properly. Activating DNAH17 with these compounds involves influencing its functional interactions and biochemical activities within the cell. Typically, DNAH17 activators possess specific structural features and chemical properties that allow them to interact with DNAH17, potentially modulating its motor function and microtubule-based movements.
Chemically, DNAH17 activators may exhibit diverse structural characteristics, reflecting the complexity of their interactions with DNAH17. These interactions may involve binding to specific domains or regions on the protein, altering its conformation, or enhancing its motor activity, all of which can lead to functional changes in DNAH17. By targeting DNAH17, these activators offer valuable tools for researchers to explore the intricate pathways and cellular processes governed by this dynein motor protein. The study of DNAH17 activators contributes to our understanding of the molecular mechanisms underlying ciliary and flagellar movement, cellular motility, and the broader biological significance of DNAH17 in the context of cell biology and molecular physiology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
These compounds inhibit histone deacetylases, leading to a more open chromatin structure and potentially affecting gene expression. | ||||||
(−)-Huperzine A | 102518-79-6 | sc-200183 sc-200183A | 1 mg 5 mg | $143.00 $362.00 | 1 | |
These agents inhibit DNA methyltransferases, altering DNA methylation patterns and potentially affecting gene expression. | ||||||
Hydrocortisone | 50-23-7 | sc-300810 | 5 g | $102.00 | 6 | |
Steroid hormones that regulate gene expression by interacting with glucocorticoid receptors. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Regulates gene expression through retinoic acid receptors. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Increases cAMP levels, influencing various signaling pathways and potentially gene expression. | ||||||
Thymosin β4 | 77591-33-4 | sc-396076 sc-396076A | 1 mg 100 mg | $134.00 $7140.00 | ||
A cytokine that regulates cell growth and differentiation, potentially affecting gene expression. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activate protein kinase C, leading to changes in gene expression. | ||||||